Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematologic abnormalities in patients with renal diseases.

W G Hocking1

  • 1Department of Medicine, University of Wisconsin, Marshfield.

Hematology/Oncology Clinics of North America
|June 1, 1987
PubMed
Summary

Renal diseases cause various blood disorders, often due to toxin buildup, which may improve with dialysis. Anemia in kidney failure stems from low erythropoietin, now treatable with recombinant forms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase.

Leukemia research·1999
Same author

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission.

Leukemia research·1999
Same author

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission.

Leukemia research·1998
Same author

The treatment of older adult patients with acute myeloid leukemia by triple infusion chemotherapy.

American journal of clinical oncology·1995
Same author

Utility of red cell mass determination.

Mayo Clinic proceedings·1991
Same author

Polycythemia: evaluation and management.

Blood reviews·1989

Area of Science:

  • Nephrology
  • Hematology

Background:

  • Renal diseases are linked to diverse hematologic abnormalities.
  • These include issues with red blood cell production, platelet function, and immune responses.

Purpose of the Study:

  • To explore hematologic abnormalities in renal diseases.
  • To highlight the role of uremic toxins and erythropoietin in anemia.
  • To discuss hematologic manifestations of renal cell carcinoma.

Main Methods:

  • Review of hematologic findings in acute and chronic renal failure.
  • Analysis of the impact of uremic toxins.
  • Consideration of recombinant human erythropoietin's role.
  • Examination of hematologic signs associated with renal cell carcinoma.

Main Results:

  • Uremic toxins, especially middle molecules, contribute to hematologic issues, potentially treatable with dialysis.
  • Anemia in renal failure is primarily due to insufficient erythropoietin production.
  • Recombinant erythropoietin has advanced anemia management in renal patients.
  • Unusual hematologic manifestations can signal renal cell carcinoma.

Conclusions:

  • Hematologic abnormalities are common in renal disease and linked to uremia.
  • Understanding these links aids in managing anemia and detecting renal tumors.
  • Dialysis and erythropoietin therapy are key in managing renal-related blood disorders.

Related Experiment Videos